Cardiac effects of aldosterone: Does gender matter?

Steroids

Volumn 91, Issue , 2014, Pages 32-37

  Mihailidou, Anastasia S ^a   Ashton, Anthony W ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Androgens; Estrogen; Mineralocorticoid receptor; Sex differences

Indexed keywords

ALDOSTERONE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; SEX HORMONE;

ALDOSTERONE BLOOD LEVEL; APOPTOSIS; AUTOPHAGY; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CELL SURVIVAL; HEART; HEART FUNCTION; HEART MUSCLE CELL; HUMAN; LUTEAL PHASE; NEW YORK HEART ASSOCIATION CLASS; NONHUMAN; PROTEIN EXPRESSION; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SEX DIFFERENCE; ANIMAL; BLOOD; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENOME; MALE; METABOLISM; PHYSIOLOGY; SEXUAL DEVELOPMENT;

ALDOSTERONE; ANIMALS; FEMALE; GENE EXPRESSION REGULATION; GENOME; GONADAL STEROID HORMONES; HEART; HUMANS; MALE; SEX CHARACTERISTICS;

EID: 84908689040     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2014.08.013     Document Type: Review

References (100)

1. V. Vaccarino, L. Parsons, and N.R. Every Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants N Engl J Med 341 1999 217 225
2. V.L. Roger, A.S. Go, and D.M. Lloyd-Jones Heart disease and stroke statistics - 2012 update: a report from the American Heart Association Circulation 125 2012 e2 e220
3. D.M. Bell, and J. Nappi Myocardial infarction in women: a critical appraisal of gender differences in outcomes Pharmacotherapy 20 2000 1034 1044
4. M. Izadnegahdar, J. Singer, M.K. Lee, M. Gao, C.R. Thompson, and J. Kopec Do younger women fare worse? Sex differences in acute myocardial infarction hospitalization and early mortality rates J Womens Health 23 2013 1 8
5. M. Piro, R. Della Bona, A. Abbate, L.M. Biasucci, and F. Crea Sex-related differences in myocardial remodeling J Am Coll Cardiol 55 2010 1057 1065
6. H.M. Krumholz, M. Larson, and D. Levy Sex differences in cardiac adaptation to isolated systolic hypertension J Am Coll Cardiol 72 1993 310 313
7. R.S. Vasan, J.C. Evans, E.J. Benjamin, D. Levy, M.G. Larson, and J. Sundstrom Relations of serum aldosterone to cardiac structure gender-related differences in the Framingham heart study Hypertension 43 2004 957 962
8. S. Boulkroun, F. Beuschlein, and G.-P. Rossi Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism Hypertension 59 2012 592 598
9. S.A.S. Tait, J.F. Tait, and J.P. Coghlan The discovery, isolation and identification of aldosterone: reflections on emerging regulation and function Mol Cell Endocrinol 217 2004 1 21
10. E.P. Gomez-Sanchez, N. Ahmad, and D.G. Romero Gomez-Sanchez CE Is aldosterone synthesized within the rat brain? Am J Physiol Endocrinol Metab 288 2005 E342 E346
11. A. McCurley, P.W. Pires, S.B. Bender, M. Aronovitz, M.J. Zhao, and D. Metzger Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors Nat Med 18 2012 1429 1433
12. M. Caprio, B. Fève, A. Claës, S. Viengchareun, M. Lombès, and M.C. Zennaro Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis FASEB J 21 2007 2185 2194
13. J.L. Wilkinson-Berka, G. Tan, K. Jaworski, and A.G. Miller Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology Circ Res 104 2009 124 133
14. C.G. Brilla, and K.T. Weber Mineralocorticoid excess, dietary sodium, and myocardial fibrosis J Lab Clin Med 120 1992 893 901
15. M. Young, M. Fullerton, R. Dilley, and J. Funder Mineralocorticoids, hypertension, and cardiac fibrosis J Clin Invest 93 1994 2578 2583
16. A.S. Mihailidou, T.Y.L. Le, M. Mardini, and J.W. Funder Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction Hypertension 54 2009 1306 1312
17. J. Yang, and P.J. Fuller Interactions of the mineralocorticoid receptor - within and without Mol Cell Endocrinol 350 2012 196 205
18. H. Hayashi, M. Kobara, M. Abe, N. Tanaka, E. Gouda, and H. Toba Aldosterone nongenomically produces NADPH oxidase-dependent reactive oxygen species and induces myocyte apoptosis Hypertens Res 31 2008 363 375
19. R. Alzamora, L. Michea, and E.T. Marusic Role of 11beta-hydroxysteroid dehydrogenase in nongenomic aldosterone effects in human arteries Hypertension 35 2000 1099 1104
20. A.S. Mihailidou, M. Mardini, and J.W. Funder Rapid, nongenomic effects of aldosterone in the heart mediated by epsilon protein kinase C Endocrinology 145 2004 773 780
21. M.B. Nolly, C.I. Caldiz, A.M. Yeves, M.C. Villa-Abrille, P.E. Morgan, and N.A. Mondaca The signaling pathway for aldosterone-induced mitochondrial production of superoxide anion in the myocardium J Mol Cell Cardiol 67 2014 60 68
22. J.C. Barbato, P.J. Mulrow, J.I. Shapiro, and R. Franco-Saenz Rapid effects of aldosterone and spironolactone in the isolated working rat heart Hypertension 40 2002 130 135
23. W. Chai, I.M. Garrelds, U. Arulmani, R.G. Schoemaker, J.M. Lamers, and A.H. Danser Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective? Br J Pharmacol 145 2005 664 671
24. 2+levels, and vasoconstriction in mesenteric resistance vessels Endocrinology 146 2005 973 980
25. K. Rossol-Haseroth, Q. Zhou, S. Braun, B. Boldyreff, E. Falkenstein, and M. Wehling Mineralocorticoid receptor antagonists do not block rapid ERK activation by aldosterone Biochem Biophys Res Commun 318 2004 281 288
26. C. Grossmann, and M. Gekle Nongenotropic aldosterone effects and the EGFR: interaction and biological relevance Steroids 73 2008 973 978
27. R. Gros, Q. Ding, M. Davis, R. Shaikh, B. Liu, and J. Chorazyczewski Delineating the receptor mechanisms underlying the rapid vascular contractile effects of aldosterone and estradiol Can J Physiol Pharmacol 89 2011 655 663
28. R. Gros, Q. Ding, B. Liu, J. Chorazyczewski, and R.D. Feldman Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation Am J Physiol Cell Physiol 304 2013 C532 C540
29. N. Tsybouleva, L. Zhang, S. Chen, R. Patel, S. Lutucuta, and S. Nemoto Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy Circulation 109 2004 1284 1291
30. T. Nakahara, Y. Takata, Y. Hirayama, K. Asano, H. Adachi, and G. Shiokawa Left ventricular hypertrophy and geometry in untreated essential hypertension is associated with blood levels of aldosterone and procollagen type III amino-terminal peptide Circ J 71 2007 716 721
31. M. Young, G. Head, and J. Funder Determinants of cardiac fibrosis in experimental hypermineralocorticoid states Am J Physiol 269 1995 E657 E662
32. S. Kagiyama, K. Matsumura, M. Fukuhara, K. Sakagami, K. Fujii, and M. Iida Aldosterone-and-salt-induced cardiac fibrosis is independent from angiotensin II type 1a receptor signaling in mice Hypertens Res 30 2007 979 989
33. M. Hayashi, T. Tsutamoto, A. Wada, K. Maeda, N. Mabuchi, and T. Tsutsui Relationship between transcardiac extraction of aldosterone and left ventricular remodeling in patients with first acute myocardial infarction: extracting aldosterone through the heart promotes ventricular remodeling after acute myocardial infarction J Am Coll Cardiol 38 2001 1375 1382
34. R.A.P. Weir, I.K. Tsorlalis, T. Steedman, H.J. Dargie, R. Fraser, and J.J.V. McMurray Aldosterone and cortisol predict medium-term left ventricular remodelling following myocardial infarction Eur J Heart Failure 13 2011 1305 1313
35. G. Güder, J. Bauersachs, S. Frantz, D. Weismann, B. Allolio, and G. Ertl Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure Circulation 115 2007 1754 1761
36. F. Ivanes, S. Susen, F. Mouquet, P. Pigny, F. Cuilleret, and K. Sautiere Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure Eur Heart J 33 2012 191 202
37. H. Tsuji, F.J. Venditti, J.C. Evans, M.G. Larson, and D. Levy The associations of levels of serum potassium and magnesium with ventricular premature complexes (the Framingham heart study) Am J Cardiol 74 1994 232 235
38. +pump Circ Res 86 2000 37 42
39. P. Komentiani, J. Li, L. Gnudi, B.B. Kahn, A. Askari, and Z. Xie Multiple signal transduction pathways link Na1/K1-ATPase to growth-related genes in cardiac myocytes J Biol Chem 24 1998 15249 15256
40. S. Kathiresan, M.G. Larson, E.J. Benjamin, D. Corey, J.M. Murabito, and C.S. Fox Clinical and genetic correlates of serum aldosterone in the community: the Framingham heart study AJH 18 2005 657 665
41. J.A. Miller, L.A. Anacta, and D.C. Cattran Impact of gender on the renal response to angiotensin II Kidney Int 55 1999 278 285
42. M. Chidambaram, J.A. Duncan, V.S. Lai, D.C. Cattran, J.S. Floras, and J.W. Scholey Variation in the renin angiotensin system throughout the normal menstrual cycle J Am Soc Nephrol 13 2002 446 452
43. E.D. Szmuilowicz, G.K. Adler, J.S. Williams, D.E. Green, T.M. Yao, and P.N. Hopkins Relationship between aldosterone and progesterone in the human menstrual cycle J Clin Endocrinol Metab 91 2006 3981 3987
44. M. Stowasser, P.J. Taylor, E. Pimenta, A.H. Al-Asaly Ahmed, and R.D. Gordon Laboratory investigation of primary aldosteronism Clin Biochem Rev 31 2010 39 56
45. G.K. Adler, T.J. Moore, N.K. Hollenberg, and G.H. Williams Changes in adrenal responsiveness and potassium balance with shifts in sodium intake Endocr Res 13 1987 419 445
46. A.A. Ismail, P.L. Walker, M.L. Cawood, and J.H. Barth Interference in immunoassay is an underestimated problem Ann Clin Biochem 39 2002 366 373
47. U. Turpeinen, E. Hamalainen, and U.-H. Stenman Determination of aldosterone in serum by liquid chromatography-tandem mass spectrometry J Chromatogr B 862 2008 113 118
48. U. Ceglarek, L. Kortz, A. Leichtle, G.M. Fiedler, J. Kratzsch, and J. Thiery Rapid quantification of steroid patterns in human serum by on-line solid phase extraction combined with liquid chromatography-triple quadrupole linear ion trap mass spectrometry Clin Chim Acta 401 2009 114 118
49. A.B. Chapman, S. Zamudio, W. Woodmansee, A. Merouani, F. Osorio, and A. Johnson Systemic and renal hemodynamic changes in the luteal phase of the menstrual cycle mimic early pregnancy Am J Physiol 279 1997 F777 F782
50. R.L. Landau, and K. Lugibihl Inhibition of the sodium-retaining influence of aldosterone by progesterone J Clin Endocrinol Metab 18 1958 1237 1245
51. G. Wambach, and J.R. Higgins Antimineralocorticoid action of progesterone in the rat: correlation of the effect on electrolyte excretion and interaction with renal mineralocorticoid receptors Endocrinology 102 1978 1686 1693
52. M. Quinkler, B. Meyer, C. Bumke-Vogt, C. Grossmann, U. Gruber, and W. Oelkers Agonistic and antagonistic properties of progesterone metabolites at the human mineralocorticoid receptor Eur J Endocrinol 146 2002 789 799
53. G.E. Abraham, R. Swerdloff, D. Tulchinsky, and W.D. Odell Radioimmunoassay of plasma progesterone J Clin Endocr 32 1971 619 624
54. U. Westphal, S.D. Stroupe, and S.-L. Cheng Progesterone binding to serum proteins Ann NY Acad Sci 286 1977 10 28
55. A. Nath, and R. Sitruk-Ware Different cardiovascular effects of progestins according to structure and activity Climacteric 12 2009 96 101
56. R. Hoshi-Fukushima, H. Nakamoto, H. Imai, Y. Kanno, Y. Ishida, and Y. Yamanouchi Estrogen and angiotensin II interactions determine cardio-renal damage in Dahl salt-sensitive rats with heart failure Am J Nephrol 28 2008 413 423
57. R.M. Kanashiro-Takeuchi, B. Heidecker, G. Lamirault, J.W. Dharamsi, and J.M. Hare Sex-specific impact of aldosterone receptor antagonism on ventricular remodeling and gene expression after myocardial infarction Clin Transl Sci 2 2009 134 142
58. T.Y.L. Le, A.W. Ashton, M. Mardini, P.G. Stanton, J.W. Funder, and D.J. Handelsman Role of androgens in sex differences in cardiac damage during myocardial infarction Endocrinology 155 2014 568 575
59. G.G. Biondi-Zoccai, A. Abate, R. Bussani, D. Camilot, F.D. Giorgio, and M.P. Marino Reduced post-infarction myocardial apoptosis in women: a clue to their different clinical course? Heart 91 2005 99 101
60. C.J. Malkin, P.J. Pugh, P.D. Morris, S. Asif, T.H. Jones, and K.S. Channer Low serum testosterone and increased mortality in men with coronary heart disease Heart 96 2010 1821 1825
61. D. Sieveking, P. Lim, R. Chow, L. Dunn, S. Bao, and K. McGrath A sex-specific role for androgens in angiogenesis J Exp Med 207 2010 345 352
62. J. Sánchez-Más, M.C. Turpín, A. Lax, J.A. Ruipérez, M.V. Chávarri, and D.A. Pascual-Figal Differential actions of eplerenone and spironolactone on the protective effect of testosterone against cardiomyocyte apoptosis in vitro Rev Esp Cardiol 63 2010 779 787
63. K. Sikaris, R.I. McLachlan, R. Kazlauskas, D. de Kretser, C.A. Holden, and D.J. Handelsman Reproductive hormone reference intervals for healthy fertile young men: evaluation of automated platform assays J Clin Endocrinol Metab 90 2005 5928 5936
64. M. Stowasser, A.W. Bachmann, P.R. Huggard, T.R. Rossetti, and R.D. Gordon Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance J Clin Endocrinol Metab 85 2000 2160 2166
65. F. Edelmann, A. Tomaschitz, R. Wachter, G. Gelbrich, M. Knoke, and H.-D. Dungen Serum aldosterone and its relationship to left ventricular structure and geometry in patients with preserved left ventricular ejection fraction Eur Heart J 33 2012 203 212
66. B. Xue, D. Badaue-Passos Jr., F. Guo, C.E. Gomez-Sanchez, M. Hay, and A.K. Johnson Sex differences and central protective effect of 17beta-estradiol in the development of aldosterone/NaCl-induced hypertension Am J Physiol Heart Circ Physiol 296 2009 H1577 H1585
67. P.A. Arias-Loza, K. Hu, C. Dienesch, A.M. Mehlich, S. Konig, and V. Jazbutyte Both estrogen receptor subtypes, alpha and beta, attenuate cardiovascular remodelling in aldosterone salt-treated rats Hypertension 50 2007 432 438
68. C.S. Cook, L. Zhang, G.B. Ames, J. Fischer, J. Zhang, and S. Levin Single- and repeated-dose pharmacokinetics of eplerenone, a selective aldosterone receptor blocker, in rats Xenobiotica 33 2003 305 321
69. E.R. Prossnitz, J.B. Arterburn, and H.O. Smith Estrogen signaling through the transmembrane G protein-coupled receptor GPR30 Annu Rev Physiol 70 2008 165 190
70. A.M. Deschamps, and E. Murphy Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats Am J Physiol Heart Circ Physiol 297 2009 H1806 H1813
71. B.R. Weil, M.C. Manukyan, J.L. Herrmann, Y. Wang, A.M. Abarbanell, and J.A. Poynter Signaling via GPR30 protects the myocardium from ischemia/reperfusion injury Surgery 148 2010 436 443
72. Le TYL, Ashton AW, Mardini M, Gomez-Sanchez C, Mihailidou AS. Aldosterone-induced cardiac damage during myocardial infarction: is there a role for non-genomic pathways. In: 39th International Aldosterone Conference; 2013.
73. C. Otto, I. Fuchs, G. Kauselmann, H. Kern, B. Zevnik, and P. Andreasen GPR30 does not mediate estrogenic responses in reproductive organs in mice Biol Reprod 80 2009 34 41
74. L. Kang, X. Zhang, Y. Xie, Y. Tu, D. Wang, and Z. Liu Involvement of estrogen receptor variant ER-α36, not GPR30, in nongenomic estrogen signaling Mol Endocrinol 24 2010 709 721
75. E. Lizotte, S.A. Grandy, A. Tremblay, B.G. Allen, and C. Fiset Expression, distribution and regulation of sex steroid hormone receptors in mouse heart Cell Physiol Biochem 23 2009 75 86
76. V.H. Patel, J. Chen, M. Ramanjaneyam, E. Karteris, E. Zachariades, and P. Thomas G-protein coupled estrogen receptor 1 expression in rat and human heart: protective role during ischaemic stress Int J Mol Med 26 2010 193 199
77. C.E. Gomez-Sanchez, A.F. de Rodriguez, and D.G. Romero Development of a panel of monoclonal antibodies against the mineralocorticoid receptor Endocrinology 147 2006 1343 1348
78. M. Lombès, M.E. Oblin, J.M. Gasc, E.E. Baulieu, N. Farman, and J.P. Bonvalet Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor Circ Res 71 1992 503 510
79. P. Pearce, and J.W. Funder High affinity aldosterone binding sites (type I receptors) in rat heart Clin Exp Pharmacol Physiol 14 1987 859 866
80. S. Messaoudi, B. Gravez, A. Tarjus, V. Pelloux, A. Ouvrard-Pascaud, and C. Delcayre Aldosterone-specific activation of cardiomyocyte mineralocorticoid receptor in vivo Hypertension 61 2013 361 367
81. M.M. de Resende, K. Kauser, and J.G. Mill Regulation of cardiac and renal mineralocorticoid receptor expression by captopril following myocardial infarction in rats Life Sci 78 2006 3066 3073
82. E. Milik, E. Szczepanska-Sadowska, and W. Maslinski Enhanced expression of mineralocorticoid receptors in the heart after the myocardial infarct in rats J Physiol Pharmacol 58 2007 745 755
83. M. Takeda, T. Tatsumi, S. Matsunaga, H. Hayashi, M. Kimata, and S. Honsho Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts Hypertens Res 30 2007 427 437
84. M. Yoshida, J. Ma, and T. Tomita Mineralocorticoid receptor is overexpressed in cardiomyocytes of patients with congestive heart failure Congest Heart Fail 11 2005 12 16
85. C. Helsen, and F. Claessens Looking at nuclear receptors from a new angle Mol Cell Endocrinol 382 2014 97 106
86. A. Ouvrard-Pascaud, Y. Sainte-Marie, J.P. Benitah, R. Perrier, C. Soukaseum, and A.N. Cat Conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias Circulation 111 2005 3025 3033
87. A. Di Zhang, A. Nguyen Dinh Cat, C. Soukaseum, B. Escoubet, A. Cherfa, and S. Messaoudi Cross-talk between mineralocorticoid and angiotensin II signaling for cardiac remodeling Hypertension 52 2008 1060 1067
88. A. Lother, S. Berger, R. Gilsbach, S. Rösner, A. Ecke, and F. Barreto Ablation of mineralocorticoid receptors in myocytes but not in fibroblasts preserves cardiac function Hypertension 57 2011 746 754
89. D. Fraccarollo, S. Berger, P. Galuppo, S. Kneitz, L. Hein, and G. Schutz Deletion of cardiomyocyte mineralocorticoid receptor ameliorates adverse remodeling after myocardial infarction Circulation 123 2011 400 408
90. B. Escoubet, C. Couffigna, J.-P. Laisy, L. Mangin, S. Chillon, and C. Laouénan Cardiovascular effects of aldosterone: insight from adult carriers of mineralocorticoid receptor mutations Circ Cardiovasc Genet 6 2013 381 390
91. S.K. Sia, H.L. Chiou, S.C. Chen, C.F. Tsai, S.F. Yang, and K.C. Ueng Distribution and phenotypic expression of mineralocorticoid receptor and CYP11B2 T-344C polymorphisms in a Taiwanese hypertensive population Mol Biol Rep 40 2013 3705 3711
92. X. Cheng, and G. Xu A systemic review of the relationship between aldosterone synthase - 344 C/T polymorphism and hypertension in Han Clin Exp Hypertens 32 5 2010 301 307
93. R.M. Millis Epigenetics and hypertension Curr Hypertens Rep 13 2011 21 28
94. H.W. Tsai, P.A. Grant, and E.F. Rissman Sex differences in histone modifications in the neonatal mouse brain Epigenetics 4 2009 47 53
95. B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, and A. Perez The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators N Engl J Med 341 1999 709 717
96. B. Pitt, W. Remme, F. Zannad, J. Neaton, F. Martinez, and B. Roniker Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309 1321
97. F. Zannad, J.J. McMurray, H. Krum, D.J. van Veldhuisen, K. Swedberg, and H. Shi EMPHASIS-HF Study Group. Eplerenone in patients with systolic heart failure and mild symptoms N Engl J Med 364 2011 11 21
98. M.F. Rousseau, O. Gurne, D. Duprez, W. Van Mieghem, A. Robert, and A. Ahn Beneficial Neurohormonal Profile of Spironolactone in Severe Congestive Heart Failure Results From the RALES Neurohormonal Substudy J Am Coll Cardiol 40 2002 1596 1601
99. K. Komukaia, S. Mochizukib, and M. Yoshimura Gender and the renin-angiotensin-aldosterone system Fundam Clin Pharmacol 24 2010 687 698
100. B. Pitt, M.A. Pfeffer, S.F. Assmann, R. Boineau, I.S. Anand, and B. Claggett Spironolactone for heart failure with preserved ejection fraction N Engl J Med 370 2014 1383 1392